Literature DB >> 15648260

Area/moment and compartmental modeling of pharmacokinetics during pregnancy: applications to maternal/fetal exposures to corticosteroids in sheep and rats.

Mahesh N Samtani1, Matthias Schwab, Peter W Nathanielsz, William J Jusko.   

Abstract

PURPOSE: The pharmacokinetics of corticosteroids in pregnancy were analyzed to assess maternal/fetal disposition and factors controlling fetal exposure. Area/Moment equations and compartmental models for estimating pharmacokinetic parameters from single dose data during pregnancy were developed.
METHODS: Betamethasone in the maternal/fetal circulations of sheep was measured by HPLC after maternal intramuscular injection (n = 4) of 170 microg kg(-1) of a depot formulation. Additional data for beta-methasone in sheep and dexamethasone pharmacokinetics in rats were obtained from the literature. Area/Moment equations were derived using mass balance concepts, statistical moments, and Laplace theory. Area/Moment analysis, compartmental modeling, and allometric scaling to man for betamethasone were performed using WinNonlin and ADAPT II programs.
RESULTS: Polyexponential maternal/fetal profiles for corticosteroids were observed. Clearance terms for corticosteroid transfer from fetus to mother were 4-fold higher than the clearance term for transfer in the opposite direction. A placental efflux process may restrict fetal access of corticosteroids which are known PGP substrates. The elimination clearance estimates indicate that fetal metabolism plays a minor role in corticosteroid elimination.
CONCLUSIONS: Generalized and specific models for maternal/fetal pharmacokinetics were developed. An efflux transport mechanism, such as the known placental expression of PGP, could explain the limited fetal exposure of corticosteroids.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15648260     DOI: 10.1007/s11095-004-7681-7

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  61 in total

Review 1.  Placental transporters relevant to drug distribution across the maternal-fetal interface.

Authors:  V Ganapathy; P D Prasad; M E Ganapathy; F H Leibach
Journal:  J Pharmacol Exp Ther       Date:  2000-08       Impact factor: 4.030

2.  Multidrug resistance P-glycoprotein hampers the access of cortisol but not of corticosterone to mouse and human brain.

Authors:  A M Karssen; O C Meijer; I C van der Sandt; P J Lucassen; E C de Lange; A G de Boer; E R de Kloet
Journal:  Endocrinology       Date:  2001-06       Impact factor: 4.736

3.  Diphenhydramine disposition in the sheep maternal-placental-fetal unit: gestational age, plasma drug protein binding, and umbilical blood flow effects on clearance.

Authors:  S Kumar; G R Tonn; K W Riggs; D W Rurak
Journal:  Drug Metab Dispos       Date:  2000-03       Impact factor: 3.922

4.  A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants.

Authors:  G C Liggins; R N Howie
Journal:  Pediatrics       Date:  1972-10       Impact factor: 7.124

5.  Distribution of dexamethasone between mother and fetus after maternal administration.

Authors:  J D Funkhouser; K J Peevy; P B Mockridge; E R Hughes
Journal:  Pediatr Res       Date:  1978-11       Impact factor: 3.756

6.  The role of the efflux transporter P-glycoprotein in brain penetration of prednisolone.

Authors:  A M Karssen; O C Meijer; I C J van der Sandt; A G De Boer; E C M De Lange; E R De Kloet
Journal:  J Endocrinol       Date:  2002-10       Impact factor: 4.286

7.  Steroid treatment, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells.

Authors:  K M Barnes; B Dickstein; G B Cutler; T Fojo; S E Bates
Journal:  Biochemistry       Date:  1996-04-16       Impact factor: 3.162

8.  In vitro metabolism of dexamethasone (DEX) in human liver and kidney: the involvement of CYP3A4 and CYP17 (17,20 LYASE) and molecular modelling studies.

Authors:  E S Tomlinson; D F Lewis; J L Maggs; H K Kroemer; B K Park; D J Back
Journal:  Biochem Pharmacol       Date:  1997-09-01       Impact factor: 5.858

Review 9.  Efflux transporters of the human placenta.

Authors:  Amber M Young; Courtni E Allen; Kenneth L Audus
Journal:  Adv Drug Deliv Rev       Date:  2003-01-21       Impact factor: 15.470

10.  Disposition of betamethasone in parturient women after intramuscular administration.

Authors:  M C Petersen; J J Ashley; W G McBride; R L Nation
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

View more
  9 in total

1.  Stability of dexamethasone sodium phosphate in rat plasma.

Authors:  Mahesh N Samtani; William J Jusko
Journal:  Int J Pharm       Date:  2005-09-14       Impact factor: 5.875

2.  Precocious glucocorticoid exposure reduces skeletal muscle satellite cells in the fetal rat.

Authors:  Ganga Gokulakrishnan; Xiaoyan Chang; Ryan Fleischmann; Marta L Fiorotto
Journal:  J Endocrinol       Date:  2017-01-17       Impact factor: 4.286

3.  Comparison of dexamethasone pharmacokinetics in female rats after intravenous and intramuscular administration.

Authors:  Mahesh N Samtani; William J Jusko
Journal:  Biopharm Drug Dispos       Date:  2005-04       Impact factor: 1.627

Review 4.  Transitioning from Basic toward Systems Pharmacodynamic Models: Lessons from Corticosteroids.

Authors:  Vivaswath S Ayyar; William J Jusko
Journal:  Pharmacol Rev       Date:  2020-04       Impact factor: 25.468

5.  Betamethasone pharmacokinetics after two prodrug formulations in sheep: implications for antenatal corticosteroid use.

Authors:  Mahesh N Samtani; Matthias Lohle; Angela Grant; Peter W Nathanielsz; William J Jusko
Journal:  Drug Metab Dispos       Date:  2005-04-28       Impact factor: 3.922

6.  Quantification of dexamethasone and corticosterone in rat biofluids and fetal tissue using highly sensitive analytical methods: assay validation and application to a pharmacokinetic study.

Authors:  Mahesh N Samtani; William J Jusko
Journal:  Biomed Chromatogr       Date:  2007-06       Impact factor: 1.902

7.  Betamethasone for lung maturation: testing dose and formulation in fetal sheep.

Authors:  Alan H Jobe; Timothy J M Moss; Ilias Nitsos; Machiko Ikegami; Suhas G Kallapur; John P Newnham
Journal:  Am J Obstet Gynecol       Date:  2007-11       Impact factor: 8.661

8.  Ontogeny and the effects of exogenous and endogenous glucocorticoids on tight junction protein expression in ovine cerebral cortices.

Authors:  Anna R Duncan; Grazyna B Sadowska; Barbara S Stonestreet
Journal:  Brain Res       Date:  2009-09-26       Impact factor: 3.252

Review 9.  Antenatal corticosteroids: a reappraisal of the drug formulation and dose.

Authors:  Alan H Jobe; Matthew Kemp; Augusto Schmidt; Tsukasa Takahashi; John Newnham; Mark Milad
Journal:  Pediatr Res       Date:  2020-11-11       Impact factor: 3.756

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.